danthron has been researched along with leukotriene b4 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Christophers, E; Kosfeld, U; Schröder, JM | 1 |
| Schröder, JM | 1 |
2 other study(ies) available for danthron and leukotriene b4
| Article | Year |
|---|---|
Multifunctional inhibition by anthralin in nonstimulated and chemotactic factor stimulated human neutrophils.
Topics: Anthracenes; Anthralin; Anthraquinones; Chemotaxis, Leukocyte; Complement C5; Complement C5a; Cytoplasmic Granules; Dose-Response Relationship, Drug; Glucuronidase; Humans; Leukotriene B4; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Receptors, Immunologic; Superoxides | 1985 |
Anthralin (1,8-dihydroxyanthrone) is a potent inhibitor of leukotriene production and LTB4-omega oxidation by human neutrophils.
Topics: Anthralin; Anthraquinones; Arachidonate Lipoxygenases; Arachidonic Acid; Arachidonic Acids; Calcimycin; Humans; Hydroxyeicosatetraenoic Acids; Leukotriene B4; Lipoxygenase Inhibitors; Neutrophils; Oxidation-Reduction | 1986 |